New Drug

Parkinsn's Email List Message

Posting to the Parkinsn List is a benefit of Subscription

[Message Prev][Message Next][Thread Prev][Thread Next][Message Index][Thread Index]

New Drug

Subject: New Drug
From: Ron Reiner <rreiner@xxxxxxxxxxxxx>
Date: Tue, 9 Jul 1996 21:07:34 -0400
Reply-to: "PARKINSN: Parkinson's Disease - Information Exchange Network" <PARKINSN@xxxxxxxxxxxxxxxxxxxx>
Sender: "PARKINSN: Parkinson's Disease - Information Exchange Network" <PARKINSN@xxxxxxxxxxxxxxxxxxxx>

Hi:

I just found this blurb on NewsPage Direct.  Anyone ever here of this?  Can
anyone translate this into English?

        Ron Reiner (rreiner@xxxxxxxxxxxxx)  48 + 1yr
---------------------------------------------------------------

NBI MARKETS DOMIN TAB. - Nippon Boehringer Ingelheim began to launch
the Parkinson's disease agent Domin Tab. 0.4 on June 18. The drug is
the first treatment for the malady that is a non-ergot dopamine D2
receptor stimulant. [Comline, 116 words]

Prev by Message: Re: Subject: RE: Sinemet and protein
Next by Message: NIH (Udall) Reauthorization Delay ?
Previous by thread: Subject: RE: Sinemet and protein
Next by thread: Restless Legs
Index(es):
- Message
- Thread

Parkinsn's List Subject Index

Parkinsn's List Thread Index

Parkinsn's Archive Treasures Doctors, students, patients and caregivers find current Parkinson's information such as the Algorithm, Caregivers Handbook, and talks by respected Movement Disorder Specialists.

Mail converted by MHonArc 2.6.10

Match Keywords

Keywords:

Site Hosting donated by He.net
&
Grant from The Parkinson Alliance